Aqr Capital Management LLC Apellis Pharmaceuticals, Inc. Transaction History

Aqr Capital Management LLC

$71.5 Billion
Q3 2024

A detailed history of Aqr Capital Management LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 817,260 shares of APLS stock, worth $22.4 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

817,260

Previous 246,880 231.04%

Holding current value

$22.4 Million

Previous $9.47 Million 148.88%

% of portfolio

0.03%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$28.84 - $41.15 $16.4 Million - $23.5 Million	570,380 Added 231.04%	817,260 $23.6 Million
Q2 2024 Aug 14, 2024	BUY	$38.07 - $59.71 $7.25 Million - $11.4 Million	190,420 Added 337.27%	246,880 $9.47 Million
Q1 2024 May 15, 2024	BUY	$55.39 - $72.47 $3.13 Million - $4.09 Million	56,460 New	56,460 $3.32 Million
Q2 2023 Aug 14, 2023	SELL	$76.68 - $93.31 $326,886 - $397,780	-4,263 Reduced 28.07%	10,926 $995,000
Q1 2023 May 15, 2023	SELL	$46.59 - $66.96 $93,273 - $134,053	-2,002 Reduced 11.65%	15,189 $1 Million
Q4 2022 Feb 14, 2023	BUY	$43.24 - $61.04 $380,166 - $536,663	8,792 Added 104.68%	17,191 $888,000
Q3 2022 Nov 14, 2022	BUY	$44.76 - $69.66 $4,117 - $6,408	92 Added 1.11%	8,399 $574,000
Q2 2022 Aug 15, 2022	BUY	$35.07 - $59.21 $291,326 - $491,857	8,307 New	8,307 $376,000
Q4 2021 Feb 14, 2022	SELL	$30.74 - $49.16 $1.26 Million - $2.01 Million	-40,966 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$31.4 - $69.84 $1.15 Million - $2.55 Million	36,478 Added 812.79%	40,966 $1.35 Million
Q2 2021 Aug 16, 2021	BUY	$40.9 - $64.9 $183,559 - $291,271	4,488 New	4,488 $284,000
Q1 2021 May 17, 2021	SELL	$40.8 - $57.39 $160,792 - $226,173	-3,941 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$30.79 - $57.2 $367,263 - $682,281	-11,928 Reduced 75.17%	3,941 $225,000
Q3 2020 Nov 16, 2020	SELL	$25.89 - $33.65 $285,929 - $371,630	-11,044 Reduced 41.04%	15,869 $479,000
Q2 2020 Aug 17, 2020	SELL	$24.8 - $38.49 $180,990 - $280,900	-7,298 Reduced 21.33%	26,913 $879,000
Q1 2020 May 15, 2020	BUY	$17.91 - $44.33 $243,414 - $602,489	13,591 Added 65.91%	34,211 $917,000
Q4 2019 Feb 14, 2020	BUY	$22.1 - $30.8 $455,702 - $635,096	20,620 New	20,620 $631,000

Others Institutions Holding APLS

# of Institutions

309

Shares Held

115M

Call Options Held

3.85M

Put Options Held

1.09M

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.01B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Account

Aqr Capital Management LLC Apellis Pharmaceuticals, Inc. Transaction History